Obesity, Inflammation, and the Challenge of Exercise: How the KineDek Offers Hope

Recent studies (refer to Scientific Insight) suggest that merely increasing exercise load might not be the most effective approach for those struggling to loose weight. The traditional belief that burning more calories than one consumes may not be entirely accurate. Instead, inflammation appears to be a primary factor associated with severe overweight issues, and, surprisingly, incorrect or too much exercise might even exacerbate inflammation, and therefore contribute to weight gain.


Image Credit: Research Outreach


In the realm of health and wellness, the intertwining stories of obesity and inflammation present a dilemma. Obesity, a rampant condition in modern sedentary society, is more than just about weight. With it comes risks like heart disease, diabetes, and even certain cancers. But, the complexity doesn’t end there; obesity is intimately linked with systematic chronic inflammation (SCI), an inflammation state affecting our metabolic tissues. This inflammation can lead to insulin resistance and type 2 diabetes, painting a grim picture of the health challenges that lie ahead.

Research now points out an interesting, yet perplexing fact: losing weight through exercise may be more challenging for those who are morbidly overweight. A recent study published in Current Biology suggests that when humans indulge in strenuous exercise, our bodies compensate by limiting the energy used on essential metabolic functions. In essence, if someone burns 300 calories during an exercise session, their body might offset this by conserving energy elsewhere, especially in metabolic functions. Over time, this could result in a frustrating weight loss plateau. Notably, this phenomenon appears more pronounced in individuals with higher BMI, hinting at a possible deeper link between obesity, energy expenditure, and perhaps inflammation.

Now, let's add the KineDek into this intricate equation. With obesity driving inflammation and the body's perplexing response to exercise, how can individuals with obesity effectively break this cycle? This is where the KineDek's promise shines.

The KineDek's AI-enabled Compensating Resistance Technology (AI-CRT) offers a balanced approach to exercise. Instead of pushing the body to its limits and potentially triggering increased inflammation, the KineDek aims for a more moderated, controlled exercise regimenEach session spans around 20 minutes and comprises 5 exercises that aim for a lactate burn, engaging the whole body. The aftereffect is notably smooth: quick recovery, negligible post-exercise discomfort or stiffness, and typically no sweating. Its effectiveness is often signalled by enhanced mood, increased energy, heightened motivation, and improved sleep. Improved noticeable muscle tone often follows shortly after. 

Though brief, these sessions are impactful, curbing the body's tendency to scale down vital metabolic activities. Given the close ties between inflammation and obesity, the strategy of KineDek not just paves the way for weight reduction but also counters pervasive systemic inflammation.

Furthermore, with inflammation being a potential barrier to effective weight loss, the KineDek's potential anti-inflammatory benefits might offer a dual advantage. Not only could it help individuals with obesity achieve their weight loss goals, but by potentially reducing inflammation, it could also address one of the root causes of weight gain.

To conclude, the world of obesity, inflammation, and exercise is a labyrinth. However, tools like the KineDek offer a beacon of hope. By addressing the challenges at multiple levels, we can pave a more effective path towards holistic well-being. For those battling the intertwined challenges of obesity and inflammation, the KineDek potentially is the ally they need in this often perplexing challenge. 🌱🌟


Scientific Insight

Recent research has unveiled a malfunction in the functioning of Myokine Interleukin-6 (IL-6), a vital protein for immune system regulation, in individuals with significant obesity. IL-6 is produced in response to infections and tissue injuries, playing a role in inducing fevers in autoimmune, infectious, and non-infectious diseases. [6]

Functioning as both a pro-inflammatory cytokine and an anti-inflammatory myokine, IL-6 acts to increase inflammation when triggered by the greater endocrine and immune system as a cytokine. Conversely, when activated through muscle contraction, it is expected to have an anti-inflammatory effect. This phenomenon is known as "The IL-6 Paradox." [5&7]

This discovery underscores the critical role of muscle activity in regulating inflammation. Furthermore, it suggests that the post-exercise repair process, particularly when inducing muscle microtrauma, may be insufficient in clinically obese individuals, impairing their ability to manage inflammation. In simple terms, when microtrauma occurs in the muscles, it acts as a cytokine externally produced by the immune system. Conversely, with optimal contraction, it is produced through muscle contraction as a myokine. This observation establishes a connection between cellular repair capacity and obesity. Additionally, the resulting compromised regulation of the immune system in obese individuals may contribute to heightened overall inflammation levels.

Unfortunately, this discovery sets the stage for a detrimental cycle. Given that the primary production of IL-6 to achieve reduced inflammation relies on frequent, intense, and effective muscle use, individuals struggling to exercise or engage in vigorous activities without incurring microtrauma may experience compromised immune function. This challenge is exacerbated by the degree of obesity, creating a self-perpetuating cycle.

It's crucial to highlight that high adiposity encompasses more than just being overweight or obese; it generally includes individuals with low muscularity relative to the volume of adipose tissue, i.e., body-fat percentage (BFP). Consideration of the "Obesity (or BMI) Paradox" is important in this context, where many individuals classified as obese exhibit a higher likelihood of survival from various high-risk health conditions. In this regard, obese individuals that are mobile would require a significantly greater muscle load to conduct normal activity. In other words, theisignificantly elevated weight disposes them to engage higher intensity activity than normal. 

This increased survivability is directly linked to the degree of body mass, regardless of BMI. Additionally, low muscle mass coupled with relatively low fat (persons with very low BMI and reasonable to high BFP) significantly contribute to the risk of metabolic conditions. In this context, low muscle mass or poor muscle tone and function emerge as key indicators for the development of a host of diseases. In other words, lean muscle mass – the overall weight minus weight from body fat – is a better indicator of overall health, than either BMI or BFP. [8]

It's noteworthy that similar dynamics are at play in cancer formation and progression. [9]

For more detail on the science read "The IL-6 Enigma: Highlightingthe Complex Relationship between Exercise and Health."


Further Reading & Resources 

  1. HealthCentral: Obesity and Inflammation: A Vicious Cycle
  2. Current Biology: Energy compensation and adiposity in humans
  3. LiveStrong: Over-Exercising & Weight Gain
  4. The Guardian: Weight loss via exercise harder for obese people, data suggests
  5. Wikipedia: Interleukin 6
  6. Danish Medical Journal: From the discovery of myokines to exercise as medicine: MUSCLE-ADIPOSE CROSSTALK
  7. National Institute of Health: Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism
  8. National Library of Medicine: Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study.  
  9. Trends in Endocrinology & Metabolism: The exercise IL-6 enigma in cancer 

Popular Posts